Liver Diseases: Nottinghamshire
Commons · Question 106402 · Tabled 16 Jan 2026 · Department of Health and Social Care · Official record
Answered 2 Mar 2026
Question
Asked by Steve Yemm
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of trends in the number of patients with metabolic dysfunction-associated steatohepatitis on the NHS in (a) Nottinghamshire and (b) Mansfield con
Answer
Answered by Ashley Dalton, 2 Mar 2026
Data on hospital admission rates for metabolic dysfunction-associated steatotic liver disease (MASLD), of which metabolic dysfunction-associated steatohepatitis is a stage in some cases, is available at the Department’s Fingertips website, and can be used...